EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Myeloperoxidase impairs mucociliary transport on human airway epithelium

Allison Boboltz, Vaidehi Rathi, Sahana Kumar, Gregg A Duncan iD

Disease Models & Mechanisms · 01.06.2026 · 19 (6)

DOI: 10.1242/dmm.052764 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Disease Models & Mechanisms, online erschienen am 26.05.2026. Verfasst von Allison Boboltz und 3 weiteren Autor:innen. Beteiligte Einrichtung: Fischell Department of Bioengineering, University of Maryland, College Park, MD 20742, USA. Hauptthemen laut MEDLINE: Peroxidase, Mucociliary Clearance, Respiratory Mucosa. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, University of Maryland, Cystic Fibrosis Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Dampening neutrophil-driven inflammation in the airways remains a challenge in treating cystic fibrosis (CF) lung disease. Myeloperoxidase (MPO) is a neutrophilic enzyme that produces reactive oxygen species and is highly concentrated in CF airways. Greater MPO concentrations have previously been correlated with increased mucus plugging in bronchiectasis, suggesting that MPO could impair mucociliary transport. As such, we evaluated the impact of MPO treatment on barrier integrity, mucin production, mucus viscoelasticity and mucociliary transport in fully differentiated human airway epithelial cultures at ionic conditions reflective of healthy and CF-affected airways. Using live-cell imaging and particle velocimetry, we found that MPO inhibits mucociliary transport in vitro at CF-like and normal airway conditions. The impairment of mucus clearance by MPO was similar to that by neutrophil elastase, another neutrophilic granular enzyme that damages the host tissues and impairs airway clearance. We also found that subsequent treatment with the reducing agent, N-acetyl cysteine, could alleviate MPO-mediated mucociliary dysfunction through disulfide bond cleavage. These findings identify MPO as a therapeutic target to resolve deficits in airway clearance function in CF and related muco-obstructive lung diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PeroxidaseMucociliary ClearanceRespiratory MucosaHumansMucinsLeukocyte ElastaseViscosityMucusCystic FibrosisAcetylcysteineDisulfidesEpithelial CellsRheology

Stichwörter der Autor:innen

Airway clearanceMucolyticsMucusMyeloperoxidase

Substanzen

PeroxidaseMucinsLeukocyte ElastaseAcetylcysteineDisulfides

Autor:innen und Institutionen

  • Fischell Department of Bioengineering, University of Maryland, College Park, MD 20742, USA.
  • Biological Sciences Graduate Program, University of Maryland, College Park, MD 20742, USA.

ORCID-Profile: Gregg A Duncan

Förderung

  • NHLBI NIH HHS
  • University of Maryland
  • Cystic Fibrosis Foundation
  • National Heart, Lung, and Blood Institute

Zitieren

APA

Boboltz, A., Rathi, V., Kumar, S., & Duncan, G. A. (2026). Myeloperoxidase impairs mucociliary transport on human airway epithelium. Disease Models & Mechanisms, 19(6). https://doi.org/10.1242/dmm.052764

Vancouver

Boboltz A, Rathi V, Kumar S, Duncan GA. Myeloperoxidase impairs mucociliary transport on human airway epithelium. Disease Models & Mechanisms. 2026;19(6). doi:10.1242/dmm.052764

BibTeX
@article{Boboltz2026,
  author = {Boboltz, Allison and Rathi, Vaidehi and Kumar, Sahana and Duncan, Gregg A},
  title = {Myeloperoxidase impairs mucociliary transport on human airway epithelium},
  journal = {Disease Models & Mechanisms},
  year = {2026},
  volume = {19},
  number = {6},
  doi = {10.1242/dmm.052764}
}
Kostenlos starten →